Delivery of Aerosolized Liposomal Amikacin as a Novel Approach for the Treatment of Nontuberculous Mycobacteria in an Experimental Model of Pulmonary Infection-Reference-Cited by-同舟云学术

Delivery of Aerosolized Liposomal Amikacin as a Novel Approach for the Treatment of Nontuberculous Mycobacteria in an Experimental Model of Pulmonary Infection

Published:2014-09-29 Issue:9 Volume:9 Page:e108703
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Rose Sasha J.,Neville Mary E.,Gupta Renu,Bermudez Luiz E.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference24 articles.

1. Characterization of biofilm formation by clinical isolates of Mycobacterium avium;G Carter;J Med Microbiol,2003

2. Differential antibiotic susceptibility of Mycobacterium abscessus variants in biofilms and macrophages compared to that of planktonic bacteria;R Greendyke;Antimicrob Agents Chemother,2008

3. The ability to form biofilm influences Mycobacterium avium invasion and translocation of bronchial epithelial cells;Y Yamazaki;Cell Microbiol,2006

4. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases;DE Griffith;Am J Respir Crit Care Med,2007

5. Nontuberculous mycobacterial pulmonary infections;MM Johnson;J Thorac Dis,2014

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 비결핵항산균 치료 연구 동향;Public Health Weekly Report;2024-04-25

2. Liposome-siderophore conjugates loaded with moxifloxacin serve as a model for drug delivery against Mycobacterium tuberculosis;International Journal of Pharmaceutics;2024-04

3. Effect of Lipid Composition on the Interaction of Liposomes with THP-1-Derived Macrophages;Biological and Pharmaceutical Bulletin;2024-03-28

4. Antimicrobial Activity of Carvacrol and Its Derivatives on Mycobacterium Spp.: Systematic Review of Preclinical Studies;Future Medicinal Chemistry;2024-03-22

5. Mavintramycin A is a promising antibiotic for treating Mycobacterium avium complex infectious disease;Antimicrobial Agents and Chemotherapy;2024-03-06